Dan Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dan Lv has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Binjie Cao
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China
52 shared publications - Caili Bi
School of Basic Medical Sciences & School of Public Health, Faculty of Medicine, Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation, Yangzhou University, Yangzhou, Jiangsu 225009, PR China
52 shared publications - Haibo Sun
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China
52 shared publications - Ning Wang
Institute of Translational Medicine, Medical College Yangzhou University Yangzhou China
52 shared publications - Rui Wu
School of Life Science, Liaoning Normal University, Dalian, Liaoning, China
52 shared publications - Shiyi Yu
School of Basic Medical Sciences & School of Public Health, Faculty of Medicine, Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation, Yangzhou University, Yangzhou, Jiangsu 225009, PR China
52 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary information from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Figure legends for supplementary figures
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary information from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Figure legends for supplementary figures
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity